Anti-CGRP therapy: where does it fit in our clinics?

Following the first approvals for anti-CGRP therapy, CGRP Forum Editor, David Dodick, discusses his experience of using these new agents in clinic, and explains his approach to initiating and titrating treatment, setting target reductions in migraine days and deciding how long to continue therapy.

Read the full report here »